Cardiovascular Disease: Additive Therapies
Treatments of Interest: icosapent ethyl (Vascepa®, Amarin Pharma) rivaroxaban (Xarelto®, Janssen Pharmaceuticals) Cardiovascular disease (CVD) is a set of conditions that result primarily from the build-up of plaque in the blood vessels. Depending on where there is build-up, patients can have chest pain (“angina”), muscle pain with walking (“claudication”) and an increased risk of heart […]